title: Should cetuximab replace Cisplatin for definitive chemoradiotherapy in locally advanced head and neck cancer?
authors.forename: Nadeem
authors.initials: N
authors.lastname: Riaz
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Sherman
authors.forename: Matthew
authors.initials: M
authors.lastname: Fury
authors.forename: Nancy
authors.initials: N
authors.lastname: Lee
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D059248:Chemoradiotherapy; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D012189:Retrospective Studies
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D002945:Cisplatin